HK Stock Market Move | Photovoltaic stocks continue to rise in the near term, with top polysilicon companies planning to form a consortium for storage and procurement. It has become an industry trend to reduce losses in the third quarter.
Photovoltaic stocks continued to rise in the near term. As of the time of writing, Xinyi Solar (00968) has risen by 5.42% to HK$3.89, FLAT GLASS (06865) has risen by 4.79% to HK$12.69, New Energy (01799) has risen by 2.48% to HK$8.68, and GCL-Poly Energy (03800) has risen by 2.17% to HK$1.41.
Photovoltaic stocks continued to rise recently. As of the time of publication, XINYI SOLAR (00968) rose by 5.42% to 3.89 Hong Kong dollars; FLAT GLASS (06865) rose by 4.79% to 12.69 Hong Kong dollars; XINTE ENERGY (01799) rose by 2.48% to 8.68 Hong Kong dollars; GCL TECH (03800) rose by 2.17% to 1.41 Hong Kong dollars.
On the news front, according to Cailian News Agency, sources revealed that a highly anticipated polysilicon restructuring "consortium" platform is being planned, and the specifics of the acquisition proposal are still under discussion. It is reported that a fund with a planned size of around 70 billion yuan will be established, and it will leverage billions of funds to acquire 700 billion yuan in liabilities. On October 28th, the chairman of the polysilicon leader Xinjiang Gorges Group, Zhu Gongshan, stated that 17 leading enterprises have basically agreed to establish a consortium and are expected to complete it by 2025.
Industrial released a research report stating that the rise in polysilicon prices driven by Q3 anti-efficiency pushing, the Q3 reduction in losses in the photovoltaic main chain has become an industry trend, and the photovoltaic industry is expected to benefit from both improved performance and substantial promotion of anti-efficiency, the industry is still at the bottom of the cycle, and it is recommended to actively participate in the anti-efficiency market. Focus on the expected supply-side reforms and structural opportunities brought about by new technological changes.
Related Articles

SHINEWAY PHARM (02877) had a revenue of 2.415 billion RMB in the first three quarters, a decrease of 16.3% year-on-year.

FIRST PACIFIC (00142) has completed the proposed demerger of MAYNILAD WATER SERVICES, INC. and will independently list on the Philippine Stock Exchange.

BOAN BIOTECH (06955): Two types of Dexu Monoclonal Antibody Injections have been accepted for market approval in the United Kingdom.
SHINEWAY PHARM (02877) had a revenue of 2.415 billion RMB in the first three quarters, a decrease of 16.3% year-on-year.

FIRST PACIFIC (00142) has completed the proposed demerger of MAYNILAD WATER SERVICES, INC. and will independently list on the Philippine Stock Exchange.

BOAN BIOTECH (06955): Two types of Dexu Monoclonal Antibody Injections have been accepted for market approval in the United Kingdom.

RECOMMEND

SERES Faces Market Test in Hong Kong: Shares Open Below Issue Price Despite HK$220 Billion Market Valuation
06/11/2025

Copper Prices Surge While Former “Copper King” Who Outpaced Huawei and Tencent Falls into Decline
06/11/2025

National Energy Administration Reports New-Type Energy Storage Capacity Exceeds 100 Million Kilowatts by End‑September
06/11/2025


